Tag: stocks
Lantheus Stock Analysis: Buy or Sell? Valuation, Margins & Growth
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E and 16.9x EV/EBITDA leave less room for disappointment.
Texas Instruments Stock Analysis: Buy or Sell? Valuation, Margins & China Risk
Texas Instruments (TXN) is rated Hold as its quality and cash generation are already reflected in a rich valuation. Strong operating margins and free cash flow support the case, but China exposure and trade risk limit upside.
Telephone and Data Systems Stock Analysis: Buy or Sell? Cash Flow, Fiber Buildout & Margin
Telephone and Data Systems (TDS) is rated hold as strong free cash flow and cash-rich balance sheet support are offset by negative operating margin and execution risk in the fiber build-out. The shares look reasonably valued on cash, but durable earnings improvement is still unproven.
Public Service Enterprise Group Stock Analysis: Buy or Sell? Leverage & Cash Flow
Public Service Enterprise Group (PEG) is rated Hold as its regulated New Jersey franchise supports earnings visibility, but weak cash conversion limits upside. High leverage and only modest free cash flow keep the balance sheet from looking fully attractive at the current valuation.
Schrödinger Stock Analysis: Buy or Sell? Valuation & Cash Burn
Schrödinger (SDGR) is rated Sell because its platform quality has not yet translated into durable cash generation. The valuation still assumes stronger growth, while operating cash flow remains deeply negative and free cash flow is not consistently positive.
Oshkosh Stock Analysis: Buy or Sell? Valuation, Tariffs & NGDV Risk
Oshkosh Corporation (OSK) is rated Hold as solid cash generation and a manageable balance sheet are offset by tariff pressure and NGDV execution risk. The stock looks reasonably priced, but deferred contract costs and rising 2026 headwinds keep upside limited for now.
Nutex Health Stock Analysis: Buy or Sell? Free Cash Flow, Valuation, Reimbursement Risk
Nutex Health Inc. (NUTX) is rated Buy in this stock analysis because it is already turning revenue into strong free cash flow, with a 15.6% FCF yield and 19.2% FCF margin. The key risk is reimbursement and arbitration exposure, which could pressure earnings if disputed claims stay elevated.
Chipotle Mexican Grill Stock Analysis: Buy or Sell? Valuation & Margin
Chipotle Mexican Grill (CMG) is rated Hold because its sourcing moat and execution remain strong, but the stock already prices in more profit improvement than recent results support. TTM EV/Revenue of 4.0x and EV/EBITDA of 21.1x leave little room for disappointment as EPS growth slows.
Stereotaxis Stock Analysis: Buy or Sell? Cash Burn, Revenue, Valuation & Margins
Stereotaxis (STXS) is rated Sell as uneven revenue and ongoing cash burn outweigh the platform’s gross-margin potential. A 4.6x EV/revenue multiple looks demanding while levered free cash flow remains negative, keeping dilution and execution risk front and center.
Urban Outfitters Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
Urban Outfitters (URBN) is rated Hold as revenue growth stays ahead of key apparel peers, but free cash flow remains too thin to support a stronger call. Valuation looks fair, yet markdown pressure and weak cash conversion keep the risk/reward balanced.